Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Extensive-stage Small-cell-lung-cancer (SCLC) is a therapeutically challenging disease.
After more than two decades without clinical progress, the addition of programmed cell death protein 1 axis blockade to platinum-based chemotherapy has demonstrated sustained overall survival benefit and represents the current standard of care in the first-line setting
Immunotherapy has shown robust clinical activity in Extensive-stage Small-cell-lung-cancer (SCLC) in previous phase III trials
Wang et al. 2022d The Lancet Oncol…